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ABSTRACT 
Introduction- Two dimensional (2D) ultrasound quality has improved in recent years. 
Quantification of cardiac dimensions is important to screen and monitor certain fetal 
conditions. We assessed feasibility and reproducibility for fetal ventricular measures 
using 2D echocardiography, reported normal ranges from our cohort and compared 
estimates to other modalities. 
Materials and Methods- Mass and end-diastolic volumes were estimated by manual 
contouring in the four-chamber view using TomTec Image Arena 4.6 in end-diastole. 
Nomograms were created from smoothed centiles of measures, constructed using 
fractional polynomials after log-transformation. Results were compared to previous 
studies using other modalities. 
Results- 294 scans from 146 fetuses were included from 15+0 to 41+6 weeks gestation. 
7% of scans were unanalysable and intraobserver variability was good (Intraclass 
Correlation Coefficients for left and right ventricular mass 0.97 (0.87-0.99) and 0.99 
(0.95-1.0) respectively). Mass and volume increased exponentially showing good 
agreement with 3D mass estimates up to 28 weeks gestation. There was good agreement 
with 4D volume estimates for the left ventricle. 
Discussion- Current state-of-the-art 2D echocardiography platforms provide feasible and 
reproducible fetal ventricular measures across gestation which appear to be in good 
agreement with previously published data from other datasets using newer modalities.   
INTRODUCTION 
Two dimensional (2D) echocardiography has for a long time been considered 
the modality of choice for fetal cardiovascular imaging in the clinical setting [1]. 
Congenital heart disease has a reported incidence of 6 per 1000 live biths for moderate 
to severe forms which rises to 75 per 1000 if more mild defects are included [2]. 
Structural and functional defects can often have an impact on fetal cardiac dimensions 
including ventricular mass. Furthermore, extra-cardiac factors, such as diaphragmatic 
hernias, and maternal condition, for example diabetes, may also have an effect on fetal 
cardiac structure. Natural history data suggests certain lesions progress with reduction 
in ventricular size whereas other lesions may result in progressive hypertrophy. 
Therefore, estimation of ventricular mass for screening and monitoring purposes can aid 
in assessing the severity and clinical course of the condition in order to guide 
counselling and plan perinatal care.  
In recent years, newer modalities such as 3D and 4D sonography have emerged 
as potentially more accurate, optional adjuncts [1]. However, this has also led to parallel 
improvements in 2D technology which has resulted in better image quality and 
development of off-line quantification packages that offer a variety of automated 
measures. The purpose of our study was to evaluate state-of-the-art 2D 
echocardiography and quantification approaches for fetal echocardiography to assess 
their feasibility and reproducibility. As no 2D echocardiography reference ranges exist 
for fetal ventricular mass and volumes, we also used the acquired data to report normal 
ranges from our cohort from 15 to 42 weeks gestation. Finally, we compared the values 
obtained against other published results using newer modalities.   
MATERIALS AND METHODS 
Study overview 
We acquired echocardiographic datasets on fetuses between 15+0 and 41+6 
weeks gestation from uncomplicated, control pregnancies who were taking part in a 
longitudinal study - the Effect of Prematurity and hypertensive disorders of pregnancy 
on Offspring Cardiovascular Health (EPOCH) study (approved by South Central 
Berkshire Research Ethics Committee ref. 11/SC/0006, UKCRN/clinical trials ref. 
NCT01888770).  
Gestational age was calculated based on first trimester ultrasound. Z-scores for 
birthweight were calculated using the International Standard size at birth reference 
charts from the INTERGROWTH-21st Project [3, 4] using their online application 
(https://intergrowth21.tghn.org/global-perinatal-package/intergrowth-21st-comparison-
application/). 
Pregnancies were excluded if the offspring showed evidence of congenital 
cardiovascular disease, chromosomal abnormalities or genetic disorders in the ante or 
postnatal period. The clinical records were also used to ensure that, for the purposes of 
development of fetal normal ranges, datasets from fetuses who went on to be delivered 
following any pregnancy complications including intrauterine growth restriction, 
maternal diabetes, preterm birth (before 37 weeks gestation) and/or exposure to chronic 
or new-onset maternal hypertension [5] were excluded from analysis. 
All mothers gave written informed consent in accordance with the Declaration 
of Helsinki, and assent for involvement of their children, including permission to access 
maternal and offspring clinical records.  
Echocardiography 
Image Acquisition 
Each mother participated in between one and six fetal ultrasound scans during 
their pregnancy. Fetuses were scanned on a Philips HD9 ultrasound system with a C6-3 
curved-array transducer. During image acquisition, in a period of fetal quiescence, the 
fetal heart had to cover at least a third of the screen using an apical or basal four-
chamber view of the heart with the septum or free wall aligned parallel to the Doppler 
beam (plus or minus 10 degrees). Care was taken to visualise both AV valves opening 
and closing and the maximum diameter of both ventricles obtained. Absence of both 
maternal and fetal breathing and movements was also required. To enhance image 
resolution for post processing analysis, the frame rate was increased by minimizing the 
sector width, the gains and depth were optimised and multiple 7.5 second cine loops of 
the same four chamber view were acquired to enable offline selection of the highest 
quality loop. These were then retrospectively gated offline using TomTec Image Arena 
4.6 where end diastole was defined at the point of mitral valve closure. Head 
circumference, abdominal circumference and femur length were measured according to 
previously published protocols with the average of three measurements being used [6]. 
Esimated fetal weight (EFW) was calculated using the Hadlock formula [7]. 
  
Quantification of Ventricular Dimensions and Mass 
Left and right end diastolic volume (EDV) and ventricular mass were obtained 
by manual contouring of the endo and epicardium using TomTec Image Arena 4.6 from 
the apical four chamber view. The end diastolic frame was manually selected using the 
point of mitral valve closure as the marker. The contours were then manually set at the 
inner edge of the endocardium and the outer edge of the epicardium but within the onset 
of the pericardium. The mass and volumes were calculated by an algorthim built into 
the the package which is equivalent to the single-plane Simpson’s (Figure 1). To 
maximise reproducibility, the entirety of the septum was contoured for both left and 
right ventricular measurements as in previous studies in this field [8, 9]. All datasets 
were analysed or the analysis directly supervised by one (CA). 10 datasets were selected 
at random to assess the inter and intraobserver variability in measurement of LV and 
RV mass (CA and RU).  
Statistical Analysis 
Statistical analysis was performed using SPSS Version 20, GraphPad Prism 6.0 
and STATA, version 11.2, software (StataCorp LP, College Station, Texas, USA).  
To create the nomograms, smoothed centiles of LV and RV mass, left and right EDV, 
ratio of LV to RV mass and ventricular mass as a function of EFW (i.e. ventricular 
mass/EFW) according to gestational age were constructed using fractional polynomials. 
Where appropriate, we applied a multi-level, linear regression analysis to account for 
repeated measures [10] but there were insignificant differences when compared to 
analyses that did not account for the hierarchy of the data. LV and RV mass, LV and 
RV EDV, ratio of LV to RV mass and ventricular mass as a function of EFW exhibited 
a non-normal distribution; therefore, the data were log-transformed (natural log) to 
stabilise variance and transform the data to normality. Goodness-of-fit assessment 
incorporated: a visual inspection of the quantile-quantile (q-q) plot of the residuals, and 
a plot of fitted z-scores across gestational ages.  
RESULTS 
Study Population Characteristics 
317 fetal echocardiograms from 146 eligible fetuses without pregnancy 
complications who were born at term were analysed. 23 scans were unanalysable due to 
image quality, fetal position or movement (7%),  which left data from 294 scans to be 
used to build the nomograms. 91 (63%) of the fetuses had one analysable 
echocardiogram, 44 (30%) had two, 18 (12%)  had three, 10 (7%)  had four, 3 (2%) had 
five and one (0.6%)  fetus had six. The range of gestational age at scan was 15+0 to 
41+6 weeks. The cohort characteristics of the fetuses contributing to the nomograms are 
presented in Table 1. Intraclass Correlation Coefficients (ICC) with 95% confidence 
intervals for intra and inter-observer variability for measures of cardiac dimensions 
using TomTec Image Arena yielded  0.97 (0.87-0.99) and 0.81 (0.41-0.95) for the left 
ventricular mass and 0.99 (0.95-1.0) and 0.78 (0.35-0.94) for the right, respectively.  
Cardiac mass and volume  
Normal ranges for left and right ventricular mass and end-diastolic volume are 
displayed in Table 2 and Figure 2 with 3rd, 50th and 97th centiles displayed. These show 
that both left and right ventricular mass and EDV increase exponentially through 
gestation. 
  
Patterns of mass change 
To investigate whether mass changes in proportion to cardiac volume in the fetal 
circulation we calculated trajectories for mass to EDV ratios for both ventricles. 
Mass/EDV ratios decreased slightly as pregnancy progressed from 1.7g/ml at 16 weeks 
to 1.3g/ml at 40 weeks and 1.7g/ml to 1.1g/ml for left and right ventricles respectively 
(Figure 3A). We also studied ventricular dominance in utero, and plotted RV to LV 
mass ratio, which  increased through gestation from 0.81 at 16 weeks until term when 
mass in the two ventricles were equal (ratio of 1.0) (Figure 3B).  Development of the 
fetal myocardium stayed in line with overall body growth, with the ratio of left 
ventricular mass to estimated fetal weight being 1x10-3 at both 16 and 40 weeks and 
0.8x10-3 and 1.2x10-3 for the right respectively (Figure 3C). 
Comparison to other modalities  
Previous ultrasound studies which have published normal values and/or 
equations for fetal ventricular mass are displayed in Table 3. Figure 4A shows 
trajectories reported in these papers for ventricular mass using 3D echo and real-time 
3D echo [8, 11] overalaid on our 2D echo data. Real-time 3D generated values 
consistently greater than 3D echo by Bhat et al. [8], but there was good to excellent 
agreement between 2D and 3D echo for both the left and right ventricle mass up until 
28 weeks gestation.  
Comparison could not be made with Messing et al. for 4D ultrasound using 
spatio-temporal image correlation (STIC) with Virtual Organ Computer-aided AnaLysis 
(VOCAL) [12] as equations were not provided for mass. 
Ventricular mass estimates are derived from subtracting intraventricular from 
total volume and multiplying the remainder by estimated fetal myocardial density 
(1.050 g/cm3) [13]. We therefore compared volume estimates from our 2D data to those 
available using 4D echo from two other studies (Figure 4B) [12, 14]. These figures 
show excellent agreement between 2D and 4D estimates for the left ventricle. 
Unfortunately, the published equation for the RV EDV in the Messing et al. (2007) 
study was incorrect and could not be plotted. The results from Hamill et al. (2011) 
indicate an over-estimation of right ventricular volume by 2D methods.   
DISCUSSION 
Normal ranges of fetal heart volumetry have been published in the past using 
2D, 3D and 4D methods [8, 12, 14-20]. They all demonstrate an increase in volume 
over gestation but with wide variation between studies, probably as a result of the use of 
different methodologies. However, there has been very little published in the literature 
regarding estimates of mass.  
Previous studies 
Previous post-mortem and M-mode or 2D imaging studies have demonstrated 
that  ventricular mass increases with gestational age and body weight [21-23]. We have 
shown good agreement between 2D and 3D estimates of fetal ventricular mass up to 28 
weeks gestation, after which 3D estimates appear to generate values that are strikingly 
unrealistic, so that by 40 weeks the values are substantially greater than would be 
expected based on what is known about cardiac size after birth from neonatal 
echocardiography. This may be because estimated trajectories using real-time 3D were 
based on data from fetuses only up to 35 weeks gestation, at which point the estimate 
for left ventricular mass was 9.15g compared to 6.07g for 3D echo and our 2D estimate 
of 3.72g [11]. Interestingly, our 2D measures at this time point are most consistent with 
a previous study looking at left ventricular mass in preterm infants using cardiovascular 
magnetic resonance imaging which is considered the gold standard imaging modality 
for quantification of ventricular mass in adults [24]. This study found that  mean LV 
mass normalized to weight at scan at a mean corrected gestational age of 34+6 weeks 
was 1.39g/kg [25]. Bhat et al. (2004) using 3D echo also only included fetuses up to 37 
weeks gestation by which time estimated LV mass was lower at 8.24g but still 
substantially larger than the 4.31g estimated by 2D echo.  
There was an excellent agreement between 2D and 4D estimates for the left but 
not right ventricular end diastolic volumes [12, 14]. However, our fetal RV EDV 
estimates at 27 weeks and 37 weeks were in good agreement with previously published 
measurements in preterm and term infants of similar gestations (1.26ml vs 1.8ml at 27 
weeks and 3.88ml vs 3.7ml at 37 weeks for fetal and neonatal values respectively) [26]. 
In addition, using similar methodology in a preterm infant in a mother with gestational 
diabetes and who visually had gross hypertrophy at birth which was worse in the right 
ventricle compared to the left, we estimated right ventricular mass as 7.86g at 34 weeks 
gestation. This would place them above the 99th centile on our nomogram suggesting, 
on this case example, validity of the ranges reported in our paper. Therefore, it will be 
interesting to undertake further work to compare our normal values to those from other 
pathological cases of severe hypertrophy or dilatation.  
  
Benefits of 2D echocardiographyTraditionally, transverse views are considered 
optimal for delineation of myocardium and estimation of mass. However, transversw 
views have limits in lateral resolution and fail to take into account longitudinal 
variation. Apical or basal views are optimal for volume estimation and the mass 
estimates we studied are based on endocardial and epicardial volume estimates. Out 
study indicates apical views can be reliably used for delineation of endo and epicardial 
borders for automated mass estimation using current image analysis platforms. 
Furthermore, failure rate for this approach are lower than previously reported in studies 
that have used transverse views, such as M-mode. 
Other benefits of using 2D ultrasound over more novel technologies are that it is simple, 
faster, cheaper and more widely accessible although the Tomtec automated software 
may not be widely available especially in low income settings. It is still seen as the 
primary imaging modality for fetal echocardiography with other techniques seen as an 
optional adjunct [1].  In addition, newer techniques such as 3D ultrasound or 4D 
ultrasound using STIC requires a significant learning period both for acquisition and 
analysis [8, 12, 14]. They also involve either manually defining the contours serially at 
each plane (4D with STIC) [12] or tracing along endo and epicardial surfaces (3D) [8] 
both of which are significantly more time consuming that extraction of data from 2D 
echocardiograms. There are limitations to newer methods, such as inability to perform 
measurements at extremes of gestation [12, 20] and reliance on the fetus being in a 
optimum position with a significant period of quiescence [12, 14, 20] as well as acoustic 
shadowing and dropout [14, 20]. This results in up to a sixth of scans being unsuitable 
for analysis [8]. However, this is not an isolated problem with newer technologies; a 
previous study using M-mode to describe ventricular geometry and function reported a 
rejection rate of 21%, much higher than 7% in our study [27]. Finally, even though our 
acquisition was not gated, measurements could be timed for end diastole by offline 
gating using mitral valve closure unlike 3D ultrasound where the four chamber view can 
often only be analysed in mid-diastole [8].Limitations 
2D methods have previously been criticized as they have been shown to have a 
high level of interobserver variability compared to 3D and 4D methods especially for 
the fetal right ventricle [8, 12]. We found, however, that using our newer quantification 
package for analysis both inter and  in particular intraobserver variability was low. In 
addition, there was some variability in what was considered normal mass and volume 
from our 2D assessment throughout gestation and it has been reported that in some 
cases of pathology, the use of 2D for volume measurements can underestimate the 
severity of the diagnosis [12]. Furthermore, our automated technique was based on 
algorithms that were developed for the adult left ventricle and therefore some 
assumptions may be inaccurate in our cohort due to geometrical and maturation 
differences in the fetus. This may also explain our results from the right ventricle as we 
would have expected right ventricular dominance especially in later pregnancy. It may 
be that due to different right and left ventricular geometries the estimation of mass using 
our algorithm make it difficult to compare directly absolute values between left and 
right ventricles. However, this does not preclude using this modality as a screening tool 
where newer technologies are available, especially if serial measurements are taken by 
the same operator.  
Another potential limitation of our study was that we did not provide validation  
against an inanimate or animal model for our measures of mass. We also did not have 
access to 2D and 3 or 4D estimates from the same individual, so direct comparison of 
methodologies could not be performed. This may have been useful as we were using a 
2D single-plane method which may have resulted in inaccuracies due to geometrical 
assumptions. Single-plane methods using 2D ultrasound have previously been used in 
studies where estimation of volumes and mass have been technically challenging [28, 
29] such as the left atrium in adults demonstrating strong correlation with bi-plane 
measures [30] and the right ventricle in neonates [29] showing good agreement with 
angiography [31]. It is important to note that fetal echocardiography requires technical 
skill and even then, biplane views are not always feasible.  Therefore the requirement 
for only a four chamber view, which can usually be visualised in the majority fetuses by 
13 weeks gestation [32, 33], makes this method for determination of mass widely 
applicable.  
This study suggests that current state-of-the-art 2D echocardiography ultrasound 
platforms and off-line analysis software provides feasible and reproducible measures 
that appear to be in good agreement expected ranges generated by newer methodologies 
up to 28 weeks gestation. Our technique allows estimation of fetal ventricular mass in a 
wide range of gestations and is likely to be of value across a range of healthcare 
settings. We have also reported, for the first time, fetal normal ranges of ventricular 
mass using 2D echo from our cohort between 15+0 to 41+6 weeks gestation. Further 
work using our technique in a larger cohort with and increased number of measures 
within each gestational week would allow these nomograms to start to be used in 
clinical practice. We believe that in certain circumstances such as extremes of gestation, 
2D ultrasound may be the modality of choice in the clinical setting, and at other times 
provide a screening or monitoring test, after which other novel modalities may be used 
as adjuncts.  
  
ACKNOWLEDGMENTS 
We are grateful to all the women and babies who took part in this study. This work was 
supported by grants to Professor Paul Leeson from the British Heart Foundation 
(FS/06/024 and FS/11/65/28865). 
CONFLICTS OF INTEREST 
The authors declare no conflicts of interest.  
 
  
REFERENCES 
1. American Institute of Ultrasound in M, AIUM practice guideline for the performance of 
fetal echocardiography. J Ultrasound Med, 2013. 32(6): p. 1067-82. 
2. Hoffman JI and Kaplan S, The incidence of congenital heart disease. J Am Coll Cardiol, 
2002. 39(12): p. 1890-900. 
3. Villar J, Ismail LC, Victora CG, Ohuma EO, Bertino E, Altman DG, Lambert A, 
Papageorghiou AT, Carvalho M, Jaffer YA, Gravett MG, Purwar M, Frederick IO, Noble 
AJ, Pang RY, Barros FC, Chumlea C, Bhutta ZA, Kennedy SH, and Growth IFN, 
International standards for newborn weight, length, and head circumference by 
gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-
21st Project. Lancet, 2014. 384(9946): p. 857-868. 
4. Villar J, Giuliani F, Fenton TR, Ohuma EO, Ismail LC, Kennedy SH, and Consortium I-s, 
INTERGROWTH-21st very preterm size at birth reference charts. Lancet, 2016. 
387(10021): p. 844-845. 
5. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, and Moutquin JM, The 
classification and diagnosis of the hypertensive disorders of pregnancy: statement 
from the International Society for the Study of Hypertension in Pregnancy (ISSHP). 
Hypertens Pregnancy, 2001. 20(1): p. IX-XIV. 
6. Papageorghiou AT, Ohuma EO, Altman DG, Todros T, Cheikh Ismail L, Lambert A, Jaffer 
YA, Bertino E, Gravett MG, Purwar M, Noble JA, Pang R, Victora CG, Barros FC, 
Carvalho M, Salomon LJ, Bhutta ZA, Kennedy SH, Villar J, International F, and Newborn 
Growth Consortium for the 21st C, International standards for fetal growth based on 
serial ultrasound measurements: the Fetal Growth Longitudinal Study of the 
INTERGROWTH-21st Project. Lancet, 2014. 384(9946): p. 869-79. 
7. Hadlock FP, Harrist RB, Sharman RS, Deter RL, and Park SK, Estimation of fetal weight 
with the use of head, body, and femur measurements--a prospective study. Am J 
Obstet Gynecol, 1985. 151(3): p. 333-7. 
8. Bhat AH, Corbett V, Carpenter N, Liu N, Liu R, Wu A, Hopkins G, Sohaey R, Winkler C, 
Sahn CS, Sovinsky V, Li X, and Sahn DJ, Fetal ventricular mass determination on three-
dimensional echocardiography: studies in normal fetuses and validation experiments. 
Circulation, 2004. 110(9): p. 1054-60. 
9. Messing B, Cohen SM, Valsky DV, Shen O, Rosenak D, Lipschuetz M, and Yagel S, Fetal 
heart ventricular mass obtained by STIC acquisition combined with inversion mode and 
VOCAL. Ultrasound Obstet Gynecol, 2011. 38(2): p. 191-7. 
10. Group WMGRS, Assessment of differences in linear growth among populations in the 
WHO Multicentre Growth Reference Study. Acta Paediatr Suppl, 2006. 450: p. 56-65. 
11. Zheng M, Schaal M, Chen Y, Li X, Shentu W, Zhang P, Ashraf M, Ge S, and Sahn DJ, 
Real-time 3-dimensional echocardiographic assessment of ventricular volume, mass, 
and function in human fetuses. PLoS One, 2013. 8(3): p. e58494. 
12. Messing B, Cohen SM, Valsky DV, Rosenak D, Hochner-Celnikier D, Savchev S, and 
Yagel S, Fetal cardiac ventricle volumetry in the second half of gestation assessed by 
4D ultrasound using STIC combined with inversion mode. Ultrasound Obstet Gynecol, 
2007. 30(2): p. 142-51. 
13. Myerson SG, Montgomery HE, World MJ, and Pennell DJ, Left ventricular mass: 
reliability of M-mode and 2-dimensional echocardiographic formulas. Hypertension, 
2002. 40(5): p. 673-8. 
14. Hamill N, Yeo L, Romero R, Hassan SS, Myers SA, Mittal P, Kusanovic JP, 
Balasubramaniam M, Chaiworapongsa T, Vaisbuch E, Espinoza J, Gotsch F, Goncalves 
LF, and Lee W, Fetal cardiac ventricular volume, cardiac output, and ejection fraction 
determined with 4-dimensional ultrasound using spatiotemporal image correlation 
and virtual organ computer-aided analysis. Am J Obstet Gynecol, 2011. 205(1): p. 76 
e1-10. 
15. Schmidt KG, Silverman NH, and Hoffman JI, Determination of ventricular volumes in 
human fetal hearts by two-dimensional echocardiography. Am J Cardiol, 1995. 76(17): 
p. 1313-16. 
16. Chang FM, Hsu KF, Ko HC, Yao BL, Chang CH, Yu CH, Liang RI, and Chen HY, Fetal heart 
volume assessment by three-dimensional ultrasound. Ultrasound Obstet Gynecol, 
1997. 9(1): p. 42-8. 
17. Meyer-Wittkopf M, Cole A, Cooper SG, Schmidt S, and Sholler GF, Three-dimensional 
quantitative echocardiographic assessment of ventricular volume in healthy human 
fetuses and in fetuses with congenital heart disease. J Ultrasound Med, 2001. 20(4): p. 
317-27. 
18. Mielke G and Benda N, Cardiac output and central distribution of blood flow in the 
human fetus. Circulation, 2001. 103(12): p. 1662-8. 
19. Esh-Broder E, Ushakov FB, Imbar T, and Yagel S, Application of free-hand three-
dimensional echocardiography in the evaluation of fetal cardiac ejection fraction: a 
preliminary study. Ultrasound Obstet Gynecol, 2004. 23(6): p. 546-51. 
20. Uittenbogaard LB, Haak MC, Spreeuwenberg MD, and van Vugt JM, Fetal cardiac 
function assessed with four-dimensional ultrasound imaging using spatiotemporal 
image correlation. Ultrasound Obstet Gynecol, 2009. 33(3): p. 272-81. 
21. St John Sutton MG, Raichlen JS, Reichek N, and Huff DS, Quantitative assessment of 
right and left ventricular growth in the human fetal heart: a pathoanatomic study. 
Circulation, 1984. 70(6): p. 935-41. 
22. St John Sutton MG, Gewitz MH, Shah B, Cohen A, Reichek N, Gabbe S, and Huff DS, 
Quantitative assessment of growth and function of the cardiac chambers in the normal 
human fetus: a prospective longitudinal echocardiographic study. Circulation, 1984. 
69(4): p. 645-54. 
23. Zheng XZ, Yang B, and Wu J, Fetal left ventricular mass determination on 2-
dimensional echocardiography using area-length calculation methods. J Ultrasound 
Med, 2014. 33(2): p. 349-54. 
24. Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, and Pennell DJ, 
Comparison of interstudy reproducibility of cardiovascular magnetic resonance with 
two-dimensional echocardiography in normal subjects and in patients with heart 
failure or left ventricular hypertrophy. Am J Cardiol, 2002. 90(1): p. 29-34. 
25. Broadhouse KM, Finnemore AE, Price AN, Durighel G, Cox DJ, Edwards AD, Hajnal JV, 
and Groves AM, Cardiovascular magnetic resonance of cardiac function and 
myocardial mass in preterm infants: a preliminary study of the impact of patent ductus 
arteriosus. J Cardiovasc Magn Reson, 2014. 16: p. 54. 
26. Levy PT, Dioneda B, Holland MR, Sekarski TJ, Lee CK, Mathur A, Cade WT, Cahill AG, 
Hamvas A, and Singh GK, Right ventricular function in preterm and term neonates: 
reference values for right ventricle areas and fractional area of change. J Am Soc 
Echocardiogr, 2015. 28(5): p. 559-69. 
27. Wladimiroff JW, Vosters R, and McGhie JS, Normal cardiac ventricular geometry and 
function during the last trimester of pregnancy and early neonatal period. Br J Obstet 
Gynaecol, 1982. 89(10): p. 839-44. 
28. Hudsmith LE, Petersen SE, Francis JM, Robson MD, and Neubauer S, Normal human 
left and right ventricular and left atrial dimensions using steady state free precession 
magnetic resonance imaging. J Cardiovasc Magn Reson, 2005. 7(5): p. 775-82. 
29. Ichihashi K, Ewert P, Welmitz G, and Lange P, Changes in ventricular and muscle 
volumes of neonates. Pediatr Int, 1999. 41(1): p. 8-12. 
30. Russo C, Hahn RT, Jin Z, Homma S, Sacco RL, and Di Tullio MR, Comparison of 
echocardiographic single-plane versus biplane method in the assessment of left atrial 
volume and validation by real time three-dimensional echocardiography. J Am Soc 
Echocardiogr, 2010. 23(9): p. 954-60. 
31. Jin Z SH, Kampmann C et al., Echocardiographic right ventricular volumes and mass in 
normal children and those with atrial setpal deects pre and post closure. Cardiol. 
Young, 1993. 3 (Suppl. 1): p. 141. 
32. Gembruch U, Shi C, and Smrcek JM, Biometry of the fetal heart between 10 and 17 
weeks of gestation. Fetal Diagn Ther, 2000. 15(1): p. 20-31. 
33. Levental M, Pretorius DH, Sklansky MS, Budorick NE, Nelson TR, and Lou K, Three-
dimensional ultrasonography of normal fetal heart: comparison with two-dimensional 
imaging. J Ultrasound Med, 1998. 17(6): p. 341-8. 
 
 
  
Table 1: Fetal Cohort Characteristics 
 
Values as Mean±Standard Deviation unless stated otherwise 
* Median±Interquartile range 
 
  
  
n=146 
 
Maternal Demographics & Anthropometrics 
 
 
Age at delivery, years 31.3±4.5 
BMI at booking, kg/m2 23.8±3.8 
     Smokers, n (%) 16 (11) 
Offspring Demographics & Anthropometrics 
 
 
     Gestational age, weeks 39.9±1.3 
     Males, n (%) 80 (55) 
     Birth order* 1±1 
     Caesarean section, n (%) 23 (16) 
Birthweight, grams 3423±445 
Birthweight Z-score 0.29±0.9 
Table 2a: Normal Range for  Fetal Ventricular Mass 
 
 
LV Mass (g) RV Mass (g) 
Week P3 P50 P97 P3 P50 P97 
16 0.07 0.15 0.34 0.06 0.11 0.23 
18 0.13 0.29 0.65 0.12 0.23 0.46 
20 0.22 0.49 1.07 0.21 0.41 0.82 
22 0.35 0.75 1.62 0.33 0.66 1.31 
24 0.51 1.08 2.27 0.49 0.97 1.93 
26 0.70 1.46 3.02 0.68 1.35 2.68 
28 0.93 1.89 3.84 0.90 1.79 3.56 
30 1.19 2.37 4.71 1.16 2.29 4.55 
32 1.48 2.89 5.63 1.43 2.84 5.63 
34 1.80 3.44 6.56 1.73 3.43 6.80 
36 2.14 4.01 7.51 2.04 4.06 8.05 
38 2.51 4.61 8.45 2.38 4.71 9.35 
40 2.90 5.22 9.38 2.72 5.39 10.70 
42 3.31 5.84 10.30 3.07 6.10 12.10 
 
LV mass: P3 = exp(4.020472 + (-9.473844*(GA/10)^-1) + (-1.88*(.526187 + (-.0053485*(GA))))). P50 = 
exp(4.020472 + (-9.473844*(GA/10)^-1)). P97 = exp(4.020472 + (-9.473844*(GA/10)^-1) + (1.88*(.526187 + (-
.0053485*(GA))))) 
RV mass: P3 = exp(4.253648  + (-10.2729*(GA/10)^-1) + (-1.88*(0.3644328))). P50 = exp(4.253648  + (-
10.2729*(GA/10)^-1)). P97 = exp(4.253648  + (-10.2729*(GA /10)^-1) + (1.88*(0.3644328))) 
Table 2b: Normal Range for  Fetal Ventricular Volume 
 
 
LV EDV (ml) RV EDV (ml) 
Week P3 P50 P97 P3 P50 P97 
16 0.04 0.08 0.16 0.03 0.07 0.20 
18 0.09 0.17 0.33 0.06 0.16 0.40 
20 0.15 0.30 0.59 0.12 0.29 0.71 
22 0.24 0.47 0.94 0.21 0.49 1.12 
24 0.35 0.70 1.38 0.34 0.75 1.66 
26 0.49 0.97 1.92 0.50 1.08 2.31 
28 0.65 1.29 2.54 0.70 1.46 3.08 
30 0.83 1.65 3.25 0.93 1.91 3.95 
32 1.03 2.04 4.02 1.19 2.42 4.92 
34 1.25 2.46 4.86 1.48 2.97 5.97 
36 1.47 2.91 5.74 1.79 3.57 7.10 
38 1.71 3.38 6.67 2.13 4.21 8.30 
40 1.96 3.87 7.64 2.49 4.88 9.55 
42 2.21 4.37 8.63 2.87 5.58 10.85 
LV EDV: P3 = exp(3.917406  + (-10.25886*(GA/10)^-1) + (-1.88*(0.3618528))). P50 = exp(3.917406 + (-
10.25886*(GA/10)^-1)). P97 = exp(3.917406  + (-10.25886*(GA/10)^-1) + (1.88*(0.3618528))) 
RV EDV: P3 = exp(4.39255 + (-11.23125 *(GA/10)^-1) + (-1.88*(0.3213458 + 0.5765573*(GA/10)^-2))). P50 = 
exp(4.39255 + (-11.23125 *(GA /10)^-1)). P97 = exp(4.39255 + (-11.23125 *(GA /10)^-1) + (1.88*(0.3213458 + 
0.5765573*(GA /10)^-2)))LV indicates left ventricular; RV right ventricular; EDV end-diastolic volume; P 
percentile; GA gestational age in weeks 
Table 3: Comparison of the present study to previously published studies 
 
Authors Year Modality No. of 
datasets 
Range of 
gestation 
(weeks) 
Structural 
ventricular 
parameters measured 
Unanalysable 
datasets,  
n (%) 
Current Study  2D 317 15.0 – 41.7 LV and RV mass 
LV and RV EDV 
23  (7%) 
St John Sutton et al.*  1983 M-mode 78 20.0-38.0 LV mass 
LV and RV diastolic    
   & systolic diameters 
Septal & free wall    
    thicknesses 
2 (2.6%) 
Bhat et al. 2004 3D 90 15.5 - 37.0 LV and RV mass 15 (17%) 
Messing et al.* 2011 3D STIC + 
VOCAL 
121 21.0 - 38.0 LV and RV mass 15 (12%) 
Zheng et al.  2013 Real-time 3D 59 16.7 - 34.6 LV and RV mass 
LV and RV EDV 
LV and RV ESV 
 
7 (12%) 
 
LV indicates left ventricular; RV right ventricular; 3D three dimensional; 
STIC spatiotemporal image correlation; VOCAL Virtual Organ Computer-aided Analysis;  
EDV end-diastolic volume; ESV end-systolic volume; 2D two dimensional. 
 
*No equation/table of normal values provided by study 
 
 
  


   
 
